Nu Skin Enterprises, Inc.
NUS
$10.35
$0.292.87%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.08M | 21.12M | 107.52M | -36.11M | 8.30M |
| Total Depreciation and Amortization | 12.09M | 13.05M | 14.21M | 16.45M | 17.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.20M | 9.11M | -102.52M | 35.11M | 8.46M |
| Change in Net Operating Assets | -14.89M | -7.48M | -18.81M | 10.33M | -2.65M |
| Cash from Operations | 27.48M | 35.80M | 389.00K | 25.79M | 31.43M |
| Capital Expenditure | -9.92M | -18.00K | -13.58M | -12.58M | -8.60M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 0.00 | 193.73M | -- | -- |
| Other Investing Activities | 0.00 | 8.81M | 1.40M | -1.04M | 2.05M |
| Cash from Investing | -9.92M | 8.79M | 181.54M | -13.62M | -6.55M |
| Total Debt Issued | 40.00M | 15.00M | -- | 0.00 | 15.00M |
| Total Debt Repaid | -60.64M | -5.50M | -155.62M | -40.58M | -40.74M |
| Issuance of Common Stock | -- | 20.00K | -- | -- | -- |
| Repurchase of Common Stock | -5.04M | -- | -6.17M | -59.00K | -53.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.96M | -2.96M | -3.00M | -2.98M | -2.98M |
| Other Financing Activities | 1.76M | 2.71M | -1.50M | 0.00 | 0.00 |
| Cash from Financing | -26.88M | 9.27M | -166.30M | -43.63M | -28.78M |
| Foreign Exchange rate Adjustments | -3.06M | 6.53M | 1.25M | -9.41M | 7.39M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.37M | 60.39M | 16.89M | -40.87M | 3.50M |